Adicet Bio Funding & Investors
Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide.
adicetbio.comTotal Amount Raised: $358,624,992
Adicet Bio Funding Rounds
Series B
$80,000,000
Series B Investors
PontifaxSamsung VenturesOrbiMed AdvisorsJohnson & Johnson Robotics and Digital SolutionsNovartis Venture FundRegeneron PharmaceuticalsSeries A
$40,000,000
Series A Investors
OrbiMed AdvisorsNest.Bio VentureQuan CapitalFidelity InvestmentsRock Springs CapitalRecharge CapitalPost Ipo Equity
$98,000,000
Series A
$51,000,000
Series A Investors
OrbiMed AdvisorsNovartis Venture FundPontifaxPost Ipo Equity
$50,000,000
Series A
$25,000,000
Series A Investors
PureTech HealthSeries Unknown
$14,625,000
IPO
Unknown
Funding info provided by Diffbot.